Article
A recent study demonstrated that long-term, low-dose trimethoprim-sulfamethoxazole (TMP-SMX) was associated with a modest decrease in urinary tract infections (UTIs) in children who had had at least 1 such symptomatic infection in the past.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.